Roche’s haemophilia A drug shows meaningful bleed control in P3
December 7, 2017Research and Development Roche, haemophilia, pharma
Roche has unveiled new Phase 3 data for its haemophilia A treatment Helimbra (emicizumab) in patients over 12 years of …
Old anti-drinking drug shows potential as cancer treatment
December 7, 2017Research and Development Cancer, biotech, drugs, oncology, pharma, pharmaceutical
Disulfiram has been known as an anti-drinking compound for nearly seven decades. Initially, the compound was used in the vulcanisation …
Clinical trial transparency research reveals progress, but more to be done
December 7, 2017Medical Communications biotech, clinical trials, drugs, pharma, pharmaceutical
Bioethics international, a non-profit organisation, has published its second annual index ranking pharma companies by the transparency of data from …
Galectin Therapeutics’ share value plummets by half after NASH drug failure
December 6, 2017Research and Development Galectin Therapeutics, nash, pharma, trial failure
Galectin Therapeutics has seen its share value almost halve after its revealed that GR-MD-02, its experimental treatment for non-alcoholic steatohepatitis …
Two big pharma companies accused of false marketing
December 6, 2017Research and Development, Sales and Marketing GSK, Novartis, biotech, drugs, pharma, pharmaceutical
Novartis and GSK have been taken to court by the Australian Competition and Consumer Commission (ACCC) over allegations of falsely …
GSK commits to multi-million investment in UK life sciences sector deal
December 6, 2017Research and Development, Sales and Marketing GSK, biotech, drugs, pharma, pharmaceutical
In the latest boost to the UK’s life sciences strategy, GSK has committed £40 million to its work identifying new …
Novartis nets first acute myeloid leukaemia approval in Canada, but NICE says no
December 6, 2017Research and Development, Sales and Marketing Canada, NICE, Novartis, Rydapt, UK, acute myeloid leukaemia, leukaemia, pharma
Novartis is celebrating the news that its drug Rydapt (midostaurin) has been awarded marketing approval in Canada for the treatment …
Veeva launches upgrade to Veeva CRM Engage
December 6, 2017Medical Communications Zinc systems, biotech, drugs, pharma, pharmaceutical, veeva
Veeva took the opportunity at its European Commercial & Medical Summit to reveal the latest upgrade to its Veeva CRM …
Study reveals diet able to reverse diabetes in half of patients
December 6, 2017Research and Development biotech, diabetes, drugs, pharma, pharmaceutical
Building on their previous research emerging from Professor Roy Taylor’s work at Newcastle University, a study has found that 45.6% …
Novo Nordisk unveils hard-hitting data for two of its diabetes therapies
December 5, 2017Manufacturing and Production, Research and Development Novo Nordisk, Tresiba, Xultophy, diabetes, pharma
Novo Nordisk has lifted the curtain on new data from two of its therapies for diabetes, Xultophy (insulin degludec/liraglutide) and …
Vanilla compound found to prevent psoriasis
December 5, 2017Manufacturing and Production, Research and Development biotech, drugs, pharma, pharmaceutical, psoriasis, vanilla
Psoriasis is a big pharmaceutical market, it’s the most common autoimmune disease in the US and as many as 7.5 …
NHS talking therapies for mental health hit a high with 1.4 million referrals
December 5, 2017Manufacturing and Production, Medical Communications NHS, anxiety, depression, mental illness, pharma
New data has revealed that the number of UK patients seeking talking therapies on the NHS is on the rise, …
AbbVie posts strong psoriasis data but can it stand out from crowd?
December 5, 2017Manufacturing and Production, Research and Development AbbVie, biotech, drugs, pharma, pharmaceutical
AbbVie revealed that its IL-23 inhibitor, risankizumab, had successfully met all of its endpoints in a Phase 3 trials into …
ProcureCon Pharma 2018
December 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ProcureCon, biotech, drugs, pharma, pharmaceutical
We are proud to be partnering with the ProcureCon Pharma 2018, the only event in Europe for senior pharma procurement …
Mundipharma names Philippe Mazas as new Chief Information Officer
December 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, Philippe Mazas
Mundipharma has announced that it has appointed Philippe Mazas as its new Chief Information Officer (CIO). Mazas boasts nearly 20 …
Akili’s video game digital treatment shows promise in ADHD, eyes FDA approval
December 4, 2017Research and Development, Sales and Marketing ADHD, AKL-T01, Akili, FDA, pharma, video game
Akili, an unlisted affiliate of London-listed PureTech Health, has unveiled top-line results of AKL-T01, a novel digital medicine which takes …
The race to find an effective dengue vaccine
December 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, dengue, drugs, pharma, pharmaceutical
Derek Wallace, Global Dengue Program Head at Takeda Vaccine Business Unit, discusses the recent Phase 2 results showing its vaccine …
Recipharm commences new supply contract and completes purchase of facility in Spain
December 4, 2017Manufacturing and Production Recipharm
Recipharm AB announces that it has today commenced the supply of commercial products to Roche and completed the acquisition of …
WHO warns of worst cholera outbreak in modern history in war-torn Yemen
December 4, 2017Sales and Marketing Cholera, Saudi Arabia, WHO, Yemen, pharma
The conflict and poor economic situation in Yemen is creating a “perfect mix” for a resurgence of cholera in the …
Philippines to investigate “shameless public health scam”
December 4, 2017Sales and Marketing Sanofi, biotech, dengvaxia, drugs, pharma, pharmaceutical
The Philippines has announced that it will investigate how more than 730,000 children received a dengue vaccine, despite safety concerns …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
